Abstract
Background: The liver biopsy is the traditional gold standard for assessing liver diseases. Bleeding is the most feared complication with transcutaneous liver biopsy, with major bleed occurring in 0.8 % - 2%. Transcutaneous liver biopsy should be avoided in patients with a high risk of bleeding and those with moderate to severe ascites. Transjugular liver biopsy (TJLB) is recommended in high-risk cases; however, the procedure is expensive, technically demanding, and is not routinely available in most centers; moreover, TJLB has limitations in the focal lesion.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
